• Completed Ralliant spin-off
  • Delivered Q2 consolidated earnings per share at the high end of guidance range
  • Initiating guidance for new Fortive

EVERETT, Wash.–(BUSINESS WIRE)–Fortive Corporation (“Fortive”) (NYSE: FTV) today announced financial results for the second quarter of 2025.


“The second quarter of 2025 was pivotal for Fortive,” said Olumide Soroye, President and CEO. “We completed our spin-off of Ralliant and launched a new chapter at Fortive with a clear value creation plan to accelerate profitable growth and enhance shareholder returns. Despite uncertainty related to trade, healthcare and government spending policy impacting demand in the second quarter, we delivered strong earnings and free cash flow, reflecting the strength of our market-leading operating brands and the power of the Fortive Business System. The medium-term financial framework we shared at our recent Investor Day remains firmly intact.”

“The third quarter marks the beginning of our new chapter, and we are moving the pieces into place to drive accelerated growth. Our new leadership team is focused on executing our Fortive Accelerated strategy, including our disciplined capital allocation approach and focus on building investor trust, which will drive meaningful shareholder value creation in the years ahead,” Mr. Soroye concluded.

Financial Highlights for Second Quarter 2025

Consolidated Results, Including Precision Technologies Segment

  • GAAP diluted net EPS of $0.49; adjusted diluted net EPS of $0.90, at high-end of guidance range
  • Deployed $345 million towards share repurchases in first half of 2025

Fortive Results, Continuing Operations*

  • Revenue of $1.02 billion, down 0.4% year-over-year; core revenue decline of 0.7%
  • GAAP net income of $112 million, 11.0% margin; adjusted EBITDA of $288 million, 28.4% margin
  • GAAP diluted net EPS of $0.33; adjusted diluted net EPS of $0.58
  • GAAP operating cash flow of $205 million, Trailing Twelve Months (TTM) GAAP operating cash flow of $1,029 million; Free Cash Flow of $180 million, TTM Free Cash Flow of $939 million

Full Year 2025 Outlook, Fortive Continuing Operations*

For the full year 2025, Fortive anticipates adjusted diluted net earnings per share of $2.50 to $2.60. This outlook reflects Fortive, on a continuing operations basis.

Summary Financial Results, Fortive Continuing Operations*

Fortive Continuing Operations

Q2-25

Q2-24

Variance

Revenue

$1,016M

$1,020M

$(4)M

Reported / core growth

(0.4)% / (0.7)%

3.7% / 3.9%

 

GAAP Net Income

$112M

$112M

—%

GAAP Net Income margin

11.0%

11.0%

0 bps

Adj. EBITDA

$288M

$291M

(1.0)%

Adj. EBITDA margin

28.4%

28.6%

(20) bps

GAAP diluted net earnings per share

$0.33

$0.32

3.1%

Adj. diluted net earnings per share

$0.58

$0.56

3.6%

GAAP Operating cash flow

$205M

$218M

(6.0)%

Free cash flow

$180M

$198M

(9.1)%

TTM GAAP Operating cash flow

$1,029M

$912M

12.8%

TTM Free cash flow

$939M

$826M

13.7%

Summary Segment Financial Results, Fortive Continuing Operations*

Intelligent Operating Solutions

Q2-25

Q2-24

Variance

Revenue

$697M

$697M

$—M

Reported / core growth

0.1% / (0.2)%

3.8% / 3.3%

 

GAAP Operating profit

$171M

$173M

(1.2)%

GAAP Operating margin

24.5%

24.9%

(40) bps

Adj. EBITDA

$236M

$232M

1.7%

Adj. EBITDA margin

33.8%

33.3%

50 bps

Advanced Healthcare Solutions

Q2-25

Q2-24

Variance

Revenue

$320M

$324M

$(4)M

Reported / core growth

(1.3)% / (1.9)%

3.4% / 5.0%

 

GAAP Operating profit

$36M

$36M

—%

GAAP Operating margin

11.2%

11.0%

20 bps

Adj. EBITDA

$86M

$86M

—%

Adj. EBITDA margin

26.9%

26.6%

30 bps

* Ralliant will be reclassified as discontinued operations in the third quarter of 2025. For the purposed of this release, Fortive Continuing Operations results for the second quarter of 2025 and 2024 assume that Ralliant had been classified as discontinued operations for such earlier periods.

RALLIANT SEPARATION

On June 28, 2025 (the “Distribution Date”), Fortive completed the separation (the “Separation”) of its former Precision Technologies segment by distributing to Fortive shareholders on a pro rata basis all of the issued and outstanding common stock of Ralliant Corporation (“Ralliant”), the entity incorporated to hold such businesses. To effect the Separation, Fortive distributed to its stockholders one share of Ralliant common stock for every three shares of Fortive’s common stock outstanding held on June 16, 2025, the record date for the distribution.

Beginning with the third quarter of 2025, the Company will classify Ralliant as a discontinued operation in its financial statements, as a result of the Separation. The results of the Precision Technologies segment are included in the consolidated results of Fortive for the second quarter of 2025 and 2024. However, results for the second quarter of 2025 and 2024 indicated in this document as “continuing operations” reflect Fortive results, with the Precision Technologies segment treated as discontinued operations for such prior periods.

CONFERENCE CALL DETAILS

Fortive will discuss results and outlook during its quarterly investor conference call today starting at 12:00 p.m. ET. The call and an accompanying slide presentation will be webcast on the “Investors” section of Fortive’s website, www.fortive.com, under “Events/Presentations.” A replay of the webcast will be available at the same location shortly after the conclusion of the presentation.

The conference call can be accessed by dialing 877-407-3110 within the U.S. or by dialing 215-268-9915 outside the U.S. a few minutes before 12:00 p.m. ET and notifying the operator that you are dialing in for Fortive’s earnings conference call. A digital recording of the conference call will be available two hours after the completion of the call until Wednesday, August 13, 2025. You can access the conference call replay on the “Investors” section of Fortive’s website, www.fortive.com, under “Events/Presentations,” or by dialing 877-660-6853 within the U.S. or 201-612-7415 outside the U.S (Access ID: 13754694).

ABOUT FORTIVE

Fortive innovates essential technologies to keep our world safe and productive. Fortive’s strategic segments – Intelligent Operating Solutions and Advanced Healthcare Solutions – include iconic inventor brands with leading positions in their markets. The company’s businesses design, develop, manufacture, and market products, software, and services, building on leading brand names, innovative technologies, and strong market positions. Fortive is headquartered in Everett, Washington and employs a team of more than 10,000 research and development, manufacturing, sales, distribution, service, and administrative team members in approximately 50 countries around the world. With a culture rooted in continuous improvement, the core of our company’s operating model is the Fortive Business System. For more information please visit: www.fortive.com.

NON-GAAP FINANCIAL MEASURES

In addition to the financial measures prepared in accordance with United States generally accepted accounting principles (GAAP), this earnings release also references “adjusted net earnings,” “adjusted diluted net earnings per share,” “adjusted EBITDA”, “adjusted EBITDA margin”, “free cash flow,” and “core revenue growth,” which are non-GAAP financial measures. The reasons why we believe these measures, when used in conjunction with the GAAP financial measures, provide useful information to investors, how management uses such non-GAAP financial measures, a reconciliation of these measures to the most directly comparable GAAP measures and other information relating to these measures are included in the supplemental reconciliation schedule attached. The non-GAAP financial measures should not be considered in isolation or as a substitute for the GAAP financial measures, but should instead be read in conjunction with the GAAP financial measures. The non-GAAP financial measures used by Fortive in this release may be different from similarly-titled non-GAAP measures used by other companies. With respect to forward-looking non-GAAP measures, we have not reconciled with, or presented, corresponding forward-looking GAAP measures since doing so would require us to make assumptions with precision about acquisitions, currency translations, capital and other expenses and other similar adjustments during the future periods.

FORWARD-LOOKING STATEMENTS

Statements in this presentation that are not strictly historical, including the statements regarding anticipated financial results, impact of trade policies, including tariffs and the application thereof, global and regional economic conditions, industry trends, geopolitical events, the impact of the Separation, the anticipated U.S. federal income tax treatment of the distribution, anticipated prospects and strategies of Fortive and Ralliant, future opportunities for Fortive and Ralliant, capital allocation strategies, interest rate and current exchange rate impact, future prospects, shareholder value, and any other statements identified by their use of words like “anticipate,” “expect,” “believe,” “outlook,” “guidance,” « target », or “will” or other words of similar meaning, are “forward-looking statements” within the meaning of the United States federal securities laws. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: deterioration of or instability in the economy, the markets we serve, international trade policies and deteriorating trade relations with other countries, including imposition of tariffs and retaliatory tariffs between United States and China and other countries, responsive economic nationalism, trade restrictions, and enhanced regulation, the financial markets, geopolitical conditions and conflicts, security breaches or other disruptions of our information technology systems, supply chain constraints, our ability to adjust purchases and manufacturing capacity to reflect market conditions, reliance on sole sources of supply, contractions or lower growth rates and cyclicality of markets we serve, competition, changes in industry standards and governmental regulations, our ability to recruit and retain key employees, our ability to successfully identify, consummate, integrate and realize the anticipated value of appropriate acquisitions and successfully complete divestitures and other dispositions, our ability to develop and successfully market new products, software, and services and expand into new markets, the potential for improper conduct by our employees, agents or business partners, contingent liabilities relating to acquisitions and divestitures, impact of changes to tax laws, our compliance with applicable laws and regulations and changes in applicable laws and regulations, risks relating to international economic, geopolitical, including war and sanctions, legal, compliance and business factors, risks relating to potential impairment of goodwill and other intangible assets, currency exchange rates, tax audits and changes in our tax rate and income tax liabilities, the impact of our debt obligations on our operations, litigation and other contingent liabilities including intellectual property and environmental, health and safety matters, our ability to adequately protect our intellectual property rights, risks relating to product, service or software defects, product liability and recalls, risks relating to product manufacturing, our relationships with and the performance of our channel partners, commodity costs and surcharges, adverse effects of restructuring activities, our plans to separate into two independent, publicly-traded companies, risk related to tax treatment of our prior separations, impact of our indemnification obligation to Ralliant and Vontier, impact of changes to U.S. GAAP, labor matters, and disruptions relating to man-made and natural disasters and climate change. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our Annual Report on Form 10-K for the year ended December 31, 2024 and Quarterly Reports on Form 10-Q for the quarters ended March 28, 2025 and June 27, 2025. These forward-looking statements speak only as of the date of this presentation, and Fortive does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

FORTIVE CORPORATION AND SUBSIDIARIES

CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS

($ and shares in millions, except per share amounts)

(unaudited)

 

 

Three Months Ended

 

Six Months Ended

 

June 27, 2025

 

June 28, 2024

 

June 27, 2025

 

June 28, 2024

Sales

$

1,518.8

 

 

$

1,552.4

 

 

$

2,993.0

 

 

$

3,076.9

 

Cost of sales

 

(623.1

)

 

 

(624.1

)

 

 

(1,216.4

)

 

 

(1,244.4

)

Gross profit

 

895.7

 

 

 

928.3

 

 

 

1,776.6

 

 

 

1,832.5

 

Operating costs:

 

 

 

 

 

 

 

Selling, general and administrative

 

(564.3

)

 

 

(525.4

)

 

 

(1,106.5

)

 

 

(1,086.4

)

Research and development

 

(109.2

)

 

 

(101.1

)

 

 

(214.3

)

 

 

(205.2

)

Gain on sale of property

 

 

 

 

 

 

 

 

 

 

63.1

 

Operating profit

 

222.2

 

 

 

301.8

 

 

 

455.8

 

 

 

604.0

 

Non-operating income (expense), net:

 

 

 

 

 

 

 

Interest expense, net

 

(32.1

)

 

 

(38.7

)

 

 

(64.1

)

 

 

(82.7

)

Loss from divestiture

 

 

 

 

(25.6

)

 

 

 

 

 

(25.6

)

Other non-operating income (expense), net

 

1.9

 

 

 

(8.8

)

 

 

1.7

 

 

 

(33.0

)

Earnings before income taxes

 

192.0

 

 

 

228.7

 

 

 

393.4

 

 

 

462.7

 

Income taxes

 

(25.4

)

 

 

(33.6

)

 

 

(54.9

)

 

 

(60.2

)

Net earnings

$

166.6

 

 

$

195.1

 

 

$

338.5

 

 

$

402.5

 

 

 

 

 

 

 

 

 

Net earnings per share:

 

 

 

 

 

 

 

Basic

$

0.49

 

 

$

0.56

 

 

$

0.99

 

 

$

1.15

 

Diluted

$

0.49

 

 

$

0.55

 

 

$

0.99

 

 

$

1.13

 

Average common stock and common equivalent shares outstanding:

 

 

 

 

 

 

 

Basic

 

339.6

 

 

 

351.3

 

 

 

340.3

 

 

 

351.5

 

Diluted

 

341.7

 

 

 

354.8

 

 

 

343.2

 

 

 

355.4

 

This information is presented for reference only. A complete copy of Fortive’s Form 10-Q financial statements is available on the Company’s website (www.fortive.com).

FORTIVE CORPORATION AND SUBSIDIARIES

SEGMENT INFORMATION

($ in millions)

(unaudited)

 

 

Three Months Ended

 

Six Months Ended

 

June 27, 2025

 

June 28, 2024

 

June 27, 2025

 

June 28, 2024

Sales:

 

 

 

 

 

 

 

Intelligent Operating Solutions

$

675.7

 

 

$

677.0

 

 

$

1,347.1

 

 

$

1,342.7

 

Precision Technologies

 

523.6

 

 

 

551.8

 

 

 

1,024.2

 

 

 

1,110.8

 

Advanced Healthcare Solutions

 

319.5

 

 

 

323.6

 

 

 

621.7

 

 

 

623.4

 

Total

$

1,518.8

 

 

$

1,552.4

 

 

$

2,993.0

 

 

$

3,076.9

 

 

 

 

 

 

 

 

 

Operating Profit:

 

 

 

 

 

 

 

Intelligent Operating Solutions

$

166.7

 

 

$

173.2

 

 

$

340.4

 

 

$

337.3

 

Precision Technologies

 

93.2

 

 

 

115.3

 

 

 

180.5

 

 

 

264.4

 

Advanced Healthcare Solutions

 

39.1

 

 

 

40.2

 

 

 

65.4

 

 

 

67.7

 

Other (a)

 

(76.8

)

 

 

(26.9

)

 

 

(130.5

)

 

 

(65.4

)

Total

$

222.2

 

 

$

301.8

 

 

$

455.8

 

 

$

604.0

 

 

 

 

 

 

 

 

 

Operating Margins:

 

 

 

 

 

 

 

Intelligent Operating Solutions

 

24.7

%

 

 

25.6

%

 

 

25.3

%

 

 

25.1

%

Precision Technologies

 

17.8

%

 

 

20.9

%

 

 

17.6

%

 

 

23.8

%

Advanced Healthcare Solutions

 

12.2

%

 

 

12.4

%

 

 

10.5

%

 

 

10.9

%

Total

 

14.6

%

 

 

19.4

%

 

 

15.2

%

 

 

19.6

%

 

 

 

 

 

 

 

 

(a) Operating profit amounts in the Other category consist of unallocated corporate costs and other costs not considered part of our evaluation of reportable segment operating performance.

This information is presented for reference only. A complete copy of Fortive’s Form 10-Q financial statements is available on the Company’s website (www.fortive.com).

FORTIVE CORPORATION AND SUBSIDIARIES

CONSOLIDATED CONDENSED BALANCE SHEETS

($ and shares in millions, except per share amounts)

 

 

As of

 

June 27, 2025

 

December 31, 2024

 

(unaudited)

 

 

ASSETS

 

 

 

Current assets:

 

 

 

Cash and equivalents

$

1,832.7

 

 

$

813.3

 

Accounts receivable less allowance for doubtful accounts of $27.2 and $30.7, respectively

 

912.2

 

 

 

945.4

 

Inventories:

 

 

 

Finished goods

 

257.3

 

 

 

220.1

 

Work in process

 

117.0

 

 

 

105.4

 

Raw materials

 

236.1

 

 

 

219.3

 

Inventories

 

610.4

 

 

 

544.8

 

Prepaid expenses and other current assets

 

328.1

 

 

 

288.8

 

Total current assets

 

3,683.4

 

 

 

2,592.3

 

 

 

 

 

Property, plant and equipment, net of accumulated depreciation of $857.8 and $828.6, respectively

 

447.9

 

 

 

433.1

 

Other assets

 

509.3

 

 

 

494.7

 

Goodwill

 

10,403.7

 

 

 

10,156.0

 

Other intangible assets, net

 

3,199.9

 

 

 

3,340.0

 

Total assets

$

18,244.2

 

 

$

17,016.1

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

Current liabilities:

 

 

 

Current portion of long-term debt

$

1,905.7

 

 

$

376.2

 

Trade accounts payable

 

700.5

 

 

 

677.4

 

Accrued expenses and other current liabilities

 

1,139.4

 

 

 

1,184.8

 

Total current liabilities

 

3,745.6

 

 

 

2,238.4

 

 

 

 

 

Other long-term liabilities

 

1,202.9

 

 

 

1,251.0

 

Long-term debt

 

2,906.5

 

 

 

3,331.1

 

Commitments and Contingencies (Note 9)

 

 

 

 

 

 

 

Equity:

 

 

 

Common stock: $0.01 par value, 2.0 billion shares authorized; 368.4 and 366.6 issued; 338.2 and 341.2 outstanding; respectively

 

3.7

 

 

 

3.7

 

Additional paid-in capital

 

4,106.0

 

 

 

4,035.0

 

Treasury shares, at cost

 

(1,952.2

)

 

 

(1,612.3

)

Retained earnings

 

8,511.9

 

 

 

8,227.6

 

Accumulated other comprehensive loss

 

(287.3

)

 

 

(465.4

)

Total Fortive stockholders’ equity

 

10,382.1

 

 

 

10,188.6

 

Noncontrolling interests

 

7.1

 

 

 

7.0

 

Total stockholders’ equity

 

10,389.2

 

 

 

10,195.6

 

Total liabilities and equity

$

18,244.2

 

 

$

17,016.1

 

This information is presented for reference only. A complete copy of Fortive’s Form 10-Q financial statements is available on the Company’s website (www.fortive.com).

FORTIVE CORPORATION AND SUBSIDIARIES

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

($ in millions)

(unaudited)

 

 

Three Months Ended

 

June 27, 2025

 

June 28, 2024

Cash flows from operating activities:

 

 

 

Net earnings

$

338.5

 

 

$

402.5

 

Adjustments to reconcile net earnings to net cash provided by operating activities:

 

 

 

Amortization

 

225.0

 

 

 

227.1

 

Depreciation

 

47.7

 

 

 

46.2

 

Stock-based compensation

 

54.9

 

 

 

53.1

 

Gain on sale of property

 

 

 

 

(63.1

)

Loss from divestiture

 

 

 

 

25.6

 

Change in certain assets and liabilities:

 

 

 

Change in accounts receivable, net

 

75.5

 

 

 

24.6

 

Change in inventories

 

(57.7

)

 

 

(12.0

)

Change in trade accounts payable

 

13.8

 

 

 

30.7

 

Change in prepaid expenses and other assets

 

(40.3

)

 

 

(11.5

)

Change in accrued expenses and other liabilities

 

(104.5

)

 

 

(157.6

)

Net cash provided by operating activities

 

552.9

 

 

 

565.6

 

 

 

 

 

Cash flows from investing activities:

 

 

 

Purchases of property, plant and equipment

 

(63.4

)

 

 

(55.6

)

Proceeds from sale of property

 

1.7

 

 

 

10.8

 

Cash paid for acquisitions, net of cash received

 

 

 

 

(1,721.8

)

Cash infusion into divestiture

 

 

 

 

(14.0

)

All other investing activities

 

10.9

 

 

 

(1.6

)

Net cash used in investing activities

 

(50.8

)

 

 

(1,782.2

)

 

 

 

 

Cash flows from financing activities:

 

 

 

Net proceeds from (repayments of) commercial paper borrowings

 

(253.2

)

 

 

(571.5

)

Repurchase of common shares

 

(344.5

)

 

 

(152.9

)

Payment of common stock cash dividend to shareholders

 

(54.2

)

 

 

(56.1

)

Proceeds from borrowings (maturities greater than 90 days), net of issuance costs

 

1,146.8

 

 

 

1,733.5

 

Repayment of borrowings (maturities greater than 90 days)

 

 

 

 

(1,000.0

)

All other financing activities

 

14.4

 

 

 

31.9

 

Net cash provided by (used in) financing activities

 

509.3

 

 

 

(15.1

)

 

 

 

 

Effect of exchange rate changes on cash and equivalents

 

8.0

 

 

 

(13.0

)

Net change in cash and equivalents

 

1,019.4

 

 

 

(1,244.7

)

Beginning balance of cash and equivalents

 

813.3

 

 

 

1,888.8

 

Ending balance of cash and equivalents

$

1,832.7

 

 

$

644.1

 

This information is presented for reference only. A complete copy of Fortive’s Form 10-Q financial statements is available on the Company’s website (www.fortive.com).

FORTIVE CORPORATION UNAUDITED FINANCIAL MEASURES REFLECTING RALLIANT CORPORATION AS A DISCONTINUED OPERATION

BASIS OF PRESENTATION

The financial information for Fortive presented below is prepared on a continuing operations basis with Ralliant presented as discontinued operations. Discontinued operations reporting will be reflected retrospectively in the Company’s future filings, but in no way revises or restates any Consolidated Statements of Earnings, Consolidated Balance Sheets, Consolidated Statements of Shareholders’ Equity or Consolidated Statements of Cash Flows for the Company for any period previously filed with the U.S. Securities and Exchange Commission.

Unaudited Consolidated Condensed Statement of Earnings for Fortive Reflecting Ralliant as Discontinued Operations

($ and shares in millions, except per share amounts)

 

 

Three Months Ended

 

Six Months Ended

 

June 27, 2025

 

June 28, 2024

 

June 27, 2025

 

June 28, 2024

Sales

$

1,016.4

 

 

$

1,020.2

 

 

$

2,009.5

 

 

$

2,004.4

 

Cost of sales

 

(370.9

)

 

 

(366.6

)

 

 

(726.5

)

 

 

(722.3

)

Gross profit

 

645.5

 

 

 

653.6

 

 

 

1,283.0

 

 

 

1,282.1

 

Operating costs

 

(475.7

)

 

 

(471.3

)

 

 

(947.9

)

 

 

(950.0

)

Operating profit

 

169.8

 

 

 

182.3

 

 

 

335.1

 

 

 

332.1

 

Non-operating income (expense), net

 

(30.2

)

 

 

(47.2

)

 

 

(61.8

)

 

 

(115.1

)

Earnings from continuing operations before income taxes

 

139.6

 

 

 

135.1

 

 

 

273.3

 

 

 

217.0

 

Income taxes

 

(28.0

)

 

 

(23.1

)

 

 

(49.1

)

 

 

(39.2

)

Net earnings from continuing operations

 

111.6

 

 

 

112.0

 

 

 

224.2

 

 

 

177.8

 

Earnings from discontinued operations, net of income taxes

 

55.0

 

 

 

83.1

 

 

 

114.3

 

 

 

224.7

 

Net earnings

$

166.6

 

 

$

195.1

 

 

$

338.5

 

 

$

402.5

 

 

 

 

 

 

 

 

 

Net earnings per share from continuing operations:

 

 

 

 

 

 

 

Basic

$

0.33

 

 

$

0.32

 

 

$

0.66

 

 

$

0.51

 

Diluted

$

0.33

 

 

$

0.32

 

 

$

0.65

 

 

$

0.50

 

Net earnings per share from discontinued operations:

 

 

 

 

 

 

 

Basic

$

0.16

 

 

$

0.24

 

 

$

0.34

 

 

$

0.64

 

Diluted

$

0.16

 

 

$

0.23

 

 

$

0.34

 

 

$

0.63

 

Net earnings per share:

 

 

 

 

 

 

 

Basic

$

0.49

 

 

$

0.56

 

 

$

0.99

 

 

$

1.15

 

Diluted

$

0.49

 

 

$

0.55

 

 

$

0.99

 

 

$

1.13

 

Average common stock and common equivalent shares outstanding:

 

 

 

 

 

 

 

Basic

 

339.6

 

 

 

351.3

 

 

 

340.3

 

 

 

351.5

 

Diluted

 

341.7

 

 

 

354.8

 

 

 

343.2

 

 

 

355.4

 

 

Certain amounts may not sum due to rounding.

Segment Information Reflecting Ralliant as Discontinued Operations

($ in millions)

(unaudited)

 

 

Three Months Ended

 

Six Months Ended

 

June 27, 2025

 

June 28, 2024

 

June 27, 2025

 

June 28, 2024

Sales:

 

 

 

 

 

 

 

Intelligent Operating Solutions

$

696.9

 

 

$

696.6

 

 

$

1,387.8

 

 

$

1,381.0

 

Advanced Healthcare Solutions

 

319.5

 

 

 

323.6

 

 

 

621.7

 

 

 

623.4

 

Total

$

1,016.4

 

 

$

1,020.2

 

 

$

2,009.5

 

 

$

2,004.4

 

 

 

 

 

 

 

 

 

Operating Profit:

 

 

 

 

 

 

 

Intelligent Operating Solutions

$

170.8

 

 

$

173.4

 

 

$

345.4

 

 

$

338.2

 

Advanced Healthcare Solutions

 

35.8

 

 

 

35.7

 

 

 

57.5

 

 

 

59.1

 

Other (a)

 

(36.8

)

 

 

(26.8

)

 

 

(67.8

)

 

 

(65.2

)

Total

$

169.8

 

 

$

182.3

 

 

$

335.1

 

 

$

332.1

 

 

 

 

 

 

 

 

 

Operating Margins:

 

 

 

 

 

 

 

Intelligent Operating Solutions

 

24.5

%

 

 

24.9

%

 

 

24.9

%

 

 

24.5

%

Advanced Healthcare Solutions

 

11.2

%

 

 

11.0

%

 

 

9.2

%

 

 

9.5

%

Total

 

16.7

%

 

 

17.9

%

 

 

16.7

%

 

 

16.6

%

 

 

 

 

 

 

 

 

(a) Operating profit amounts in the Other category consist of unallocated corporate costs and other costs not considered part of our evaluation of reportable segment operating performance.

Unaudited Consolidated Condensed Balance Sheet for Fortive Assuming Ralliant as Discontinued Operations

($ and shares in millions, except per share amounts)

 

 

As of

 

June 27, 2025

 

December 31, 2024

ASSETS

 

 

 

Current assets:

 

 

 

Cash and equivalents

$

1,827.4

 

 

$

808.1

 

Other current assets

 

1,205.1

 

 

 

1,164.7

 

Current assets, discontinued operations

 

650.9

 

 

 

619.5

 

Total current assets

 

3,683.4

 

 

 

2,592.3

 

Other assets

 

10,234.1

 

 

 

10,327.8

 

Other assets, discontinued operations

 

4,326.7

 

 

 

4,096.0

 

Total assets

$

18,244.2

 

 

$

17,016.1

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

Current liabilities:

 

 

 

Current portion of long-term debt

$

1,905.7

 

 

$

376.2

 

Other current liabilities

 

1,301.8

 

 

 

1,293.7

 

Current liabilities, discontinued operations

 

538.1

 

 

 

568.5

 

Total current liabilities

 

3,745.6

 

 

 

2,238.4

 

Other long-term liabilities

 

771.6

 

 

 

847.2

 

Long-term debt

 

1,758.1

 

 

 

3,331.1

 

Long-term liabilities, discontinued operations

 

1,579.7

 

 

 

403.8

 

 

 

 

 

Equity:

 

 

 

Common stock: $0.01 par value, 2.0 billion shares authorized; 368.4 and 366.6 issued; 338.2 and 341.2 outstanding; respectively

 

3.7

 

 

 

3.7

 

Additional paid-in capital

 

4,106.0

 

 

 

4,035.0

 

Treasury shares, at cost

 

(1,952.2

)

 

 

(1,612.3

)

Retained earnings

 

8,511.9

 

 

 

8,227.6

 

Accumulated other comprehensive loss

 

(287.3

)

 

 

(465.4

)

Total Fortive stockholders’ equity

 

10,382.1

 

 

 

10,188.6

 

Noncontrolling interests

 

7.1

 

 

 

7.0

 

Total stockholders’ equity

 

10,389.2

 

 

 

10,195.6

 

Total liabilities and equity

$

18,244.2

 

 

$

17,016.1

 

Contacts

INVESTOR CONTACT
Christina Jones

Investor Relations

Fortive Corporation

6920 Seaway Boulevard

Everett, WA 98203

Telephone: (425) 446-5000

Email: investors@fortive.com

Read full story here

Fortive Reports Second Quarter 2025 Results

ACTUALITÉS ÉCONOMIQUES ET FINANCIÈRES |